Changes in Inflammatory Markers in Clinical High Risk of Developing Psychosis
Neuropsychobiology · 2023
DOI: 10.1159/000528770 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychobiology, 2023. Verfasst von TianHong Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Mental Health Center, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), S…. Hauptthemen laut MEDLINE: Interleukin-10, Psychotic Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Immune alterations are associated with the progression of psychosis. However, there are few studies designed to longitudinally measure inflammatory biomarkers during psychotic episodes. We aimed to assess changes in biomarkers from the prodromal phase to psychotic episodes in individuals with clinical high risk (CHR) of psychosis and compare converters and non-converters to psychosis as well as healthy controls (HCs).
Methods
We enrolled 394 individuals with CHR and 100 HCs. A total of 263 individuals with CHR completed the 1-year follow-up, and 47 had converted to psychosis. Interleukin (IL)-1β, 2, 6, 8, 10, tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor levels were measured at baseline and 1 year after completion of the clinical assessment.
Results
The baseline serum levels of IL-10, IL-2, and IL-6 were significantly lower in the conversion group than in the non-conversion group (IL-10, p = 0.010; IL-2, p = 0.023; IL-6, p = 0.012) and HC (IL-6: p = 0.034). Self-controlled comparisons showed that IL-2 changed significantly (p = 0.028), and IL-6 levels tended toward significance (p = 0.088) in the conversion group. In the non-conversion group, serum levels of TNF-α (p = 0.017) and VEGF (p = 0.037) changed significantly. Repeated measures analysis of variance revealed a significant time effect related to TNF-α (F = 4.502, p = 0.037, effect size (η2) = 0.051), a group effect related to IL-1β (F = 4.590, p = 0.036, η2 = 0.062), and IL-2 (F = 7.521, p = 0.011, η2 = 0.212), but no time × group effect.
Discussion
Alterations in the serum levels of inflammatory cytokines were found to precede the first episode of psychosis in the CHR population, particularly for those who later converted to psychosis. Longitudinal analysis supports the varied roles of cytokines in individuals with CHR with later psychotic conversion or non-conversion outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Mental Health Center, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai Jiaotong Unive…
- Department of Automation, Shanghai Jiao Tong University, Shanghai, China.
- Big Data Research Lab, University of Waterloo, Waterloo, Ontario, Canada.
- Labor and Worklife Program, Harvard University, Cambridge, Massachusetts, USA.
- Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Science, Shanghai, China.
- Institute of Psychology and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China.
Zitieren
APA
Zhang, T., Zeng, J., Wei, Y., Ye, J., Tang, X., Xu, L., Hu, Y., Liu, H., Chen, T., Li, C., & Wang, J. (2023). Changes in Inflammatory Markers in Clinical High Risk of Developing Psychosis. Neuropsychobiology. https://doi.org/10.1159/000528770
Vancouver
Zhang T, Zeng J, Wei Y, Ye J, Tang X, Xu L, et al. Changes in Inflammatory Markers in Clinical High Risk of Developing Psychosis. Neuropsychobiology. 2023. doi:10.1159/000528770
BibTeX
@article{Zhang2023,
author = {Zhang, TianHong and Zeng, JiaHui and Wei, YanYan and Ye, JiaYi and Tang, XiaoChen and Xu, LiHua and Hu, YeGang and Liu, HaiChun and Chen, Tao and Li, ChunBo and Wang, JiJun},
title = {Changes in Inflammatory Markers in Clinical High Risk of Developing Psychosis},
journal = {Neuropsychobiology},
year = {2023},
doi = {10.1159/000528770}
}
EUVIMED